Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 854 results for "iias"

10 public sector banks may miss out on govt's lifeline
Rediff.com

For PSU banks, raising much-needed ₹1.1-lakh cr could be tou...

10 banks face threat of capital scarcity on ownership norms Mumbai, April 6: Can public sector banks (PSBs) continue to stay relevant? Or is the governments insistence on owning at least 50 per cent of such banks going to be the death of them these are the ... Business Line, 3 weeks ago

Yes Bank picks up 5% stake in proxy advisory firm IiAS

Acquires 500,750 equity shares equivalent to 5.006% of paid-up capital
 Business Standard1 month ago YES Bank buys over 5% stake in advisory firm IiAS  Business Line1 month ago Yes Bank buys over 5% stake in investor advisory firm Institutional Investor Advisory Services  Economic Times1 month ago Yes Bank acquires 5% stake in advisory firm IiAS  Myiris1 month ago
[x]  
Rediff.com

Some proxy advisory firms object to Infosys reappointing Lehman

Two major proxy advisory firms – Stakeholders Empowerment Services (SES) and Institutional Investor Advisory Services (IIAS) – have recommended a vote against some of the resolutions that Infosys has proposed to pass through a postal ballot among its ...
 Times of India1 month ago Infy answers proxy firms' queries  Rediff.com1 month ago Infosys battles proxy advisory firms on board member re-appointment, employee stock incentive plan  Economic Times1 month ago Proxy advisory questions payment of royalties by local subsidiaries of MNCs  Business Line2 months ago
Money Control

Growth in royalty payments outpaces profit growth of 32 MNCs, says IiAs

Royalty growth outpaces their profit growth of 32 multinational companies in 2014-15
 Business Standard2 months ago 32 listed cos paid Rs 6,300 crore royalty in FY15  Money Control2 months ago Royalty payout by 32 MNCs jumps 20% to Rs 6,300 crore  The Financial Chronicle2 months ago

PSUs dilute the seriousness of governance agenda: Hetal Dalal

Interview with Chief operating officer, IiAS Sudipto Dey February 7, 2016 Last Updated at 21:29 IST Institutional Investor Advisory Services (IiAS), a proxy advisory and research firm, recently came out with a guide for shareholders to address ...
 Business Standard2 months ago

High royalty payout by MNCs continues to be a concern: IiAS

DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"
 Business Standard2 months ago

Joint USAF/NOAA Solar Geophysical Activity Report and Forecast 2 May 2016

Joint USAF/NOAA Solar Geophysical Activity Report and Forecast SDF Number 123 Issued at 2200Z on 02 May 2016 IA. Analysis of Solar Active Regions and Activity from 01/2100Z to 02/2100Z: Solar activity has been at low levels for the past 24 hours.
 SpaceRef1 hour ago

America's Missile Defense Disaster (And Music to Russia and China's Ears)

The ballistic missile threat to U.S. allies and the homeland is skyrocketing. Russia is deploying a new heavy intercontinental ballistic missile (ICBM) capable of carrying ten or more warheads. It also has a new ballistic missile submarine and ...
 National Interest3 hours ago

OTC Exhibitors Highlight Technology Developments

The Offshore Technology Conference (OTC) is where energy professionals get the chance to network, exchange ideas and discuss new technologies. The conference gives you access to technical information, an equipment exhibition and professional ...
 E&P Magazine4 hours ago

BRIEF-Thrombogenics subsidiary Oncurious initiates phase I/IIA study with TB-403

May 2Thrombogenics : * Subsidiary Oncurious, Bioinvent and Nmtrc initiating phase I/IIA study with TB-403 for treatment of medulloblastoma Source text: bit.ly/24hvbKI Further company coverage: (Gdynia Newsroom) Our top ...
 Reuters UK17 hours ago BRIEF-BioInvent, Oncurious and NMTRC starts Phase I/IIa study with TB-403  Reuters UK18 hours ago Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma  TickerTech.com18 hours ago BioInvent, Oncurious NV and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma  PipelineReview5 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - iias
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less